Medical physics

New RayStation 8A Release Adds Support for TomoDirect Treatment Delivery

Retrieved on: 
Wednesday, June 20, 2018

RaySearch has announced the release of RayStation 8A*, the latest version of its innovative radiation therapy treatment planning system.

Key Points: 
  • RaySearch has announced the release of RayStation 8A*, the latest version of its innovative radiation therapy treatment planning system.
  • Other advances in RayStation 8A include support for TomoTherapy in Plan Explorer, improvements for proton and carbon ion therapy and further integration with RayCare*, the next-generation oncology information system.
  • The release of RayStation 8A is one more step towards RaySearch's goal of unifying treatment planning for as many treatment delivery systems as possible, eliminating the complications and additional steps that arise from using multiple software systems.
  • RayStation integrates all RaySearch's advanced treatment planning solutions into a flexible treatment planning system.

Global Nuclear Medicine/Radiopharmaceuticals Market 2018-2023: Major Players are Cardinal Health, GE Healthcare, and Curium

Retrieved on: 
Tuesday, June 19, 2018

By type, the global nuclear medicine market is segmented diagnostic and therapeutic nuclear medicine.

Key Points: 
  • By type, the global nuclear medicine market is segmented diagnostic and therapeutic nuclear medicine.
  • Based on applications, the nuclear medicine market is segmented into diagnostic and therapeutic applications.
  • The SPECT application segment accounted for the largest share of the diagnostic nuclear medicine market by applications owing to the rising demand for cardiac imaging.
  • Based on procedural volume, the nuclear medicine market is segmented into volumes for diagnostic and therapeutic procedures.

Varian Installs ProBeam Cyclotron at UCLH Proton Beam Therapy Center

Retrieved on: 
Tuesday, June 19, 2018

PALO ALTO, Calif., June 19, 2018 /PRNewswire/ --Varian (NYSE: VAR) today announced the installation of a Varian ProBeam cyclotron at the proton beam therapy center at University College Hospitals London NHS Foundation Trust (UCLH) in London, England.

Key Points: 
  • PALO ALTO, Calif., June 19, 2018 /PRNewswire/ --Varian (NYSE: VAR) today announced the installation of a Varian ProBeam cyclotron at the proton beam therapy center at University College Hospitals London NHS Foundation Trust (UCLH) in London, England.
  • The cyclotron is a core piece of equipment of the ProBeam proton therapy system, and its installation is a key milestone for every new proton therapy center.
  • Varian's ProBeam system is the first to offer fully-integrated IMPT to enable more efficient adaptive proton therapy.
  • When combined with integrated cone-beam computed tomography (CBCT), the ProBeam system enables advanced adaptive therapy during the course of treatment, helping to make it a more precise form of proton therapy.

Bruker Introduces ParaVision® 360 Preclinical Imaging Software and AVANCE® NEO Systems with Advanced Multi-Receive Architecture for MRI

Retrieved on: 
Monday, June 18, 2018

It is the most advanced research-grade software for preclinical MRI, and has now also been extended to nuclear molecular imaging.

Key Points: 
  • It is the most advanced research-grade software for preclinical MRI, and has now also been extended to nuclear molecular imaging.
  • The AVANCE NEO is Bruker's next-generation, magnetic resonance console with a novel multi-channel architecture.
  • Dr. Wulf-Ingo Jung, President of the Bruker BioSpin Preclinical Imaging division, commented: "ParaVision 360 and the AVANCE NEO are new enabling platforms for seamless, multimodal preclinical imaging.
  • Dr. Tim Wokrina, Bruker's Preclinical MRI Market Manager, added: "ParaVision 360 with AVANCE NEO set new standards in preclinical imaging.

Chronos Imaging Ships First 100 Ct X-Ray Tubes Less Than 3 Months Post Acquisition

Retrieved on: 
Thursday, June 14, 2018

The company surpassed the 100th tube milestone during the third week of May late last month.

Key Points: 
  • The company surpassed the 100th tube milestone during the third week of May late last month.
  • Tamer Abbas, Director of Chronos Imaging commented: "We are delighted to announce the shipping of our one hundredth CT scanner tube.
  • Chronos Imaging is a US based company which focuses on the development, manufacturing anddistribution of diagnostic imaging medical devices and solutions.
  • For questions regarding Chronos Imaging, please contact Rudy Piskule, email:
    For recruitment enquiries or to send a CV, please email: [email protected]

Nuclear Medicine/Radiopharmaceuticals Market Worth 5.26 Billion USD by 2023

Retrieved on: 
Thursday, June 14, 2018

According to a new market research report "Nuclear Medicine/Radiopharmaceuticals Marketby Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023", published by MarketsandMarkets, the global market is expected to grow at a CAGR of 5.9% during the forecast period, to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018.

Key Points: 
  • According to a new market research report "Nuclear Medicine/Radiopharmaceuticals Marketby Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023", published by MarketsandMarkets, the global market is expected to grow at a CAGR of 5.9% during the forecast period, to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018.
  • Based on type, the Nuclear Medicine Market is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals.
  • In 2017, the Tc-99m segment accounted for the largest share of the nuclear medicine SPECT Radiopharmaceuticals Market.
  • The oncology segment is projected to account for the largest share of the PET Nuclear Medicine Market during the forecast period.

Pioneer of MR Image-Guided Radiotherapy, Washington University, Begins First Clinical Treatments with its Second ViewRay MRIdian System

Retrieved on: 
Wednesday, June 13, 2018

Siteman is the first U.S. cancer center to offer cancer therapy with both MRIdian and MRIdian Linac, furthering its leadership role in MR image-guided radiation therapy.

Key Points: 
  • Siteman is the first U.S. cancer center to offer cancer therapy with both MRIdian and MRIdian Linac, furthering its leadership role in MR image-guided radiation therapy.
  • Washington University physicians and researchers at Siteman played an integral role in the development, testing and clinical introduction of MRIdian in 2012.
  • Unlike conventional radiotherapy, MRIdian Linac technology uses high-definition MR soft-tissue imaging to visualize and track the detailed contours of the tumor and adjacent healthy tissues.
  • MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology.

Varex Imaging To Showcase Its Industrial Imaging Components At The 12th European Conference On Non-Destructive Testing

Retrieved on: 
Tuesday, June 12, 2018

SALT LAKE CITY, June 12, 2018 /PRNewswire/ -- Varex Imaging Corporation(Nasdaq: VREX) will exhibit its latest industrial imaging components at the 12th European Conference on Non-Destructive Testing in Gothenburg, Sweden from June 11-15, 2018.

Key Points: 
  • SALT LAKE CITY, June 12, 2018 /PRNewswire/ -- Varex Imaging Corporation(Nasdaq: VREX) will exhibit its latest industrial imaging components at the 12th European Conference on Non-Destructive Testing in Gothenburg, Sweden from June 11-15, 2018.
  • The annual Conference is attended by a large number of Non-Destructive Testing (NDT) specialists ranging from researchers to leading experts, all meeting to share ideas and expertise.
  • Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems.
  • With a 65+ year history of successful innovation, Varex's products are used in medical imaging as well as in industrial and security imaging applications.

Crux Quality Solutions to Acquire Remote Dosimetry Services, LLC

Retrieved on: 
Tuesday, June 12, 2018

ST. LOUIS, June 12, 2018 /PRNewswire/ -- Crux Quality Solutions , LLC (CruxQSTM), a leader in the development of radiation oncology software products and services, today announced that it has signed a Letter of Intent (LOI) to acquire Remote Dosimetry Services, LLC (RDS) out of Lucedale, MS.

Key Points: 
  • ST. LOUIS, June 12, 2018 /PRNewswire/ -- Crux Quality Solutions , LLC (CruxQSTM), a leader in the development of radiation oncology software products and services, today announced that it has signed a Letter of Intent (LOI) to acquire Remote Dosimetry Services, LLC (RDS) out of Lucedale, MS.
    "We are happy to have Alex Plowman and the entire RDS team join the CruxQS family," said Dharanipathy Rangaraj, PhD, Crux Quality Solutions Founder & CEO.
  • "We plan on integrating RDS' remote dosimetry services into our FlowBoardTM platform, which will enhance the overall efficiency of the service but more importantly client & patient experience," said Sridhar Yaddanapudi, PhD, Crux Quality Solution's Co-Founder.
  • Crux Quality Solutions, LLC (CruxQSTM) is a global software product design and services company.
  • To learn more about CruxQSTM, please visit www.cruxqs.com
    Remote Dosimetry Services, LLC (RDS) provides comprehensive remote dosimetry and physics support services.

Zecotek's Working Closely With European Healthcare OEM as It Prepares to Open Its LFS Crystal Manufacturing Facility

Retrieved on: 
Monday, June 11, 2018

The healthcare OEM originally ordered LFS crystals for a new line of high resolution positron emission tomography PET/CT medical imaging devices in October 2017.

Key Points: 
  • The healthcare OEM originally ordered LFS crystals for a new line of high resolution positron emission tomography PET/CT medical imaging devices in October 2017.
  • The OEM has also deployed personnel to assist with the setup of the crystal growing facility, with higher production volumes to commence later this year.
  • We have benefited from working closely with our customers and specifically the European healthcare OEM, in the setting up of quality control protocols to meet the highest industry standards.
  • By establishing its own crystal manufacturing facility in Shanghai, the Company is strategically positioning itself to become a dominant supplier.